Goldline Pharmaceutical IPO Allotment Status Online

The Goldline Pharmaceutical IPO allotment status will be available on the allotment date on May 15, 2026, Friday. The Goldline Pharmaceutical IPO subscription was ended on May 14, 2026, Thursday.

The investors who applied for the IPO will be able to check the Goldline Pharmaceutical IPO allotment status online on the Bigshare Services Pvt. Ltd. website or the BSE website. The IPO was subscribed 840.74 times overall. The IPO GMP went around ₹15 level after the subscription ended.

Goldline Pharmaceutical IPO

Goldline Pharmaceutical IPO Allotment Date

As per the timeline, the Goldline Pharmaceutical IPO allotment date is May 15, 2026, Friday. The investors can check the IPO allotment via the registrar website of Bigshare or the BSE website. Investors can check the allotment status online and offline with easy steps given below:

Registrar:Bigshare IPO Allotment Page
BSE: BSE IPO Allotment Page
IPO Watch:IPO Allotment Status Page

Check Goldline Pharmaceutical’ IPO Allotment Status on Registrar site?

  1. Visit Bigshare Services Pvt. Ltd. website
  2. Select IPO Name ‘Goldline Pharmaceutical’ from the drop-down menu on the page
  3. Enter details required like PAN Card, Application Number, or Demat Account Number
  4. Click on the ‘Search’ Button, and;
  5. Get your allotment on the your screen

Check Goldline Pharmaceutical IPO Allotment Status on BSE?

  1. Visit BSE India IPO Allotment Page
  2. Select the issue type: equity/debt
  3. Select IPO Name ‘Goldline Pharmaceutical’ from the drop-down menu on the page
  4. Enter details required like PAN Card or Application Number
  5. Click on the ‘Search’ Button, and;
  6. Get your allotment on the your screen

IPO Subscription Details

CategoryDay 1Day 2Day 3
QIB1.311.31180.22
NII24.46144.621,662.04
RII34.07137.45881.15
Total22.3598.80840.74

Goldline Pharmaceutical IPO Key Dates

IPO Open Date:May 12, 2026
IPO Close Date:May 14, 2026
Basis of Allotment:May 15, 2026
Refunds:May 18, 2026
Credit to Demat Account:May 18, 2026
IPO Listing Date:May 19, 2026

Business Overview

Goldline Pharmaceuticals is one of the leading companies involved in the marketing of pharmaceutical products under the name Goldline. Its products are divided into 5 segments: 1. Goldline Pharma, which includes specialities like Physicians, Orthopedics, ENT, Chest Physicians, General and Speciality Surgery, Gastroenterology, Neurology, and Urology, 2. Goldline Cardinal, which includes specialities like Physicians, Diabetologists, Endocrinologists, Cardiologists, and General Physicians, 3. Goldline Ayushman, which includes Pediatricians, Child Specialists, Neonatologists, and General Practitioners, 4. Goldline InLife, which includes Intensivists, Critical Care Consultants, Super Specialty Surgeons, and Physicians, and 5. Goldline Wellness, which includes cancer therapy. 

The company sells its products across various states, including Maharashtra, Madhya Pradesh, Odisha, Jharkhand, Tamil Nadu, Rajasthan, and Bihar. Moreover, all the products of the firm are sold and distributed under the brand Goldline.

Note for the Investors

Goldline Pharmaceutical IPO Registrar is responsible for the IPO allotment and refund process. If you have any queries regarding the Goldline Pharmaceutical IPO Allotment date and time please contact the registrar with your queries.

Goldline Pharmaceutical IPO Allotment Status FAQs


When is Goldline Pharmaceutical IPO Allotment Date?

Goldline Pharmaceutical IPO Allotment is to be available on May 15, 2026, Friday.

What will be Goldline Pharmaceutical IPO Refund Date?

The IPO refund date is May 18, 2026, Monday.

How to check the Goldline Pharmaceutical IPO Allotment Status?

Check Goldline Pharmaceutical IPO allotment status via your PAN number, the application number, or the amount deducted in your bank.

Table of Contents

Picture of Jagat Joshi

Jagat Joshi

Founder of IPOWatch, brings nearly 15 years of experience in IPO analysis and market research. He provides complete coverage of upcoming IPOs, subscription trends, grey market premiums (GMP), and post-listing performance, along with easy-to-understand reviews, insights, and analysis. In his working journey, he has worked with various platforms and received expertise in stock market analysis and primary markets.
Picture of Jagat Joshi

Jagat Joshi

Leave a Reply

Your email address will not be published. Required fields are marked *